Delayed
Australian S.E.
09:02:16 27/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.16
AUD
|
0.00%
|
|
0.00%
|
-5.88%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5.387
|
11.12
|
7.475
|
39.8
|
46.44
|
70.84
|
Enterprise Value (EV)
1 |
5.231
|
11.19
|
4.042
|
35.98
|
44.03
|
67.56
|
P/E ratio
|
-3.53
x
|
-21.4
x
|
-2.43
x
|
-9.71
x
|
-7.54
x
|
-8.56
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
368
x
|
13.5
x
|
11
x
|
40.5
x
|
185
x
|
660
x
|
EV / Revenue
|
357
x
|
13.6
x
|
5.94
x
|
36.6
x
|
175
x
|
629
x
|
EV / EBITDA
|
-2.16
x
|
-33.1
x
|
-1.64
x
|
-12.6
x
|
-7.25
x
|
-8.75
x
|
EV / FCF
|
-4.33
x
|
-100
x
|
33.9
x
|
-28
x
|
-244
x
|
-44
x
|
FCF Yield
|
-23.1%
|
-1%
|
2.95%
|
-3.57%
|
-0.41%
|
-2.27%
|
Price to Book
|
-72.2
x
|
-23.9
x
|
2.39
x
|
4.06
x
|
6.16
x
|
9.6
x
|
Nbr of stocks (in thousands)
|
35,913
|
74,130
|
2,57,758
|
3,79,008
|
4,03,833
|
4,72,254
|
Reference price
2 |
0.1500
|
0.1500
|
0.0290
|
0.1050
|
0.1150
|
0.1500
|
Announcement Date
|
16/05/19
|
30/09/19
|
30/09/20
|
30/09/21
|
30/09/22
|
28/09/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0146
|
0.8245
|
0.6799
|
0.9832
|
0.2511
|
0.1073
|
EBITDA
1 |
-2.425
|
-0.3382
|
-2.459
|
-2.859
|
-6.07
|
-7.723
|
EBIT
1 |
-2.427
|
-0.3383
|
-2.578
|
-2.933
|
-6.41
|
-8.158
|
Operating Margin
|
-16,583.11%
|
-41.03%
|
-379.13%
|
-298.36%
|
-2,552.87%
|
-7,600.86%
|
Earnings before Tax (EBT)
1 |
-2.002
|
-0.4749
|
-2.684
|
-2.994
|
-6.491
|
-8.266
|
Net income
1 |
-1.537
|
-0.4749
|
-2.684
|
-2.994
|
-5.992
|
-7.856
|
Net margin
|
-10,505.43%
|
-57.6%
|
-394.75%
|
-304.55%
|
-2,386.29%
|
-7,318.99%
|
EPS
2 |
-0.0425
|
-0.006999
|
-0.0119
|
-0.0108
|
-0.0153
|
-0.0175
|
Free Cash Flow
1 |
-1.207
|
-0.1118
|
0.1191
|
-1.285
|
-0.1805
|
-1.534
|
FCF margin
|
-8,246.45%
|
-13.55%
|
17.51%
|
-130.73%
|
-71.88%
|
-1,429.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/05/19
|
30/09/19
|
30/09/20
|
30/09/21
|
30/09/22
|
28/09/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.07
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.16
|
-
|
3.43
|
3.81
|
2.41
|
3.28
|
Leverage (Debt/EBITDA)
|
-
|
-0.2032
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1.21
|
-0.11
|
0.12
|
-1.29
|
-0.18
|
-1.53
|
ROE (net income / shareholders' equity)
|
-2,066%
|
155%
|
-202%
|
-46.2%
|
-72.7%
|
-107%
|
ROA (Net income/ Total Assets)
|
-175%
|
-25.4%
|
-64.1%
|
-24.3%
|
-37.9%
|
-49.5%
|
Assets
1 |
0.8766
|
1.87
|
4.186
|
12.32
|
15.83
|
15.88
|
Book Value Per Share
2 |
-0
|
-0.0100
|
0.0100
|
0.0300
|
0.0200
|
0.0200
|
Cash Flow per Share
2 |
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
Capex
1 |
0
|
-
|
0.09
|
1
|
0.37
|
0.01
|
Capex / Sales
|
20.68%
|
-
|
13.02%
|
101.97%
|
146.29%
|
13.67%
|
Announcement Date
|
16/05/19
|
30/09/19
|
30/09/20
|
30/09/21
|
30/09/22
|
28/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -5.88% | 5.72Cr | | -4.29% | 2.98TCr | | +44.33% | 969.41Cr | | +36.80% | 449.68Cr | | -37.06% | 238.41Cr | | -8.01% | 162.92Cr | | -30.32% | 120.41Cr | | +6.59% | 95Cr | | -41.51% | 99Cr | | -45.19% | 76Cr |
Medical Software & Technology Services
|